BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32450103)

  • 1. Achieving safer Ramadan fasting by keeping flexible glycemic targets during the day and tighter targets during the night in insulin treated people with type 2 diabetes.
    Ahmedani MY; Ghafoor E
    Diabetes Res Clin Pract; 2020 Jul; 165():108234. PubMed ID: 32450103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world Safety and Effectiveness of Insulin Glargine 300 U/mL in Participants with Type 2 Diabetes Mellitus During the Period of Ramadan in Four Countries (Egypt, Jordan, Lebanon, and Turkey): A Prospective Observational Study.
    Hassanein M; Shaltout I; Malek R; Assaad Khalil S; Ballout H; Annabi F; Shereen M
    Curr Diabetes Rev; 2024; 20(5):e110823219694. PubMed ID: 37581325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of flash glucose monitoring system in assessing safety of the SGLT2 inhibitors during Ramadan fasting in high risk insulin treated patients with type 2 diabetes.
    Abdelgadir E; Rashid F; Bashier A; Al Saeed M; Khalifa A; Alawadi F; Hassanein M
    Diabetes Metab Syndr; 2019; 13(5):2927-2932. PubMed ID: 31425958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of provision of optimum diabetes care on the safety of fasting in Ramadan in adult and adolescent patients with type 1 diabetes mellitus.
    Alawadi F; Alsaeed M; Bachet F; Bashier A; Abdulla K; Abuelkheir S; Rashid F; Abdulaziz Bin Hussain A; Abdelgadir E; Alsayyah F; Elsayed M; Hassanein M
    Diabetes Res Clin Pract; 2020 Nov; 169():108466. PubMed ID: 32971155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ramadan Prospective Diabetes Study: the role of drug dosage and timing alteration, active glucose monitoring and patient education.
    Ahmedani MY; Haque MS; Basit A; Fawwad A; Alvi SF
    Diabet Med; 2012 Jun; 29(6):709-15. PubMed ID: 22587405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of analog insulin mix 50:50 with human insulin mix 30:70 in persons with type 2 diabetes during Ramadan.
    Hajjaji IM; Eshwihdi N; Barrowman N
    Int J Clin Pract; 2019 Jun; 73(6):e13348. PubMed ID: 30912213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitigation of hypoglycemia during Ramadan using the flash glucose monitoring system following dose adjustment of insulin and sulphonylurea in patients taking multiple glucose-lowering therapies (The PROFAST-IT Study).
    Elhadd T; Bashir M; Baager KA; Ali HA; Almohannadi DHS; Dabbous Z; Malik RA; Abou-Samra AB;
    Diabetes Res Clin Pract; 2021 Feb; 172():108589. PubMed ID: 33316309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of optimum diabetes care on the safety of fasting in Ramadan in adult patients with type 2 diabetes mellitus on insulin therapy.
    Bashier AMK; Hussain AKB; Alawadi F; Alsayyah F; Alsaeed M; Rashid F; Abdelgadir E; Bachet F; Abuelkheir S; Elsayed M; Hassanein M
    Diabetes Res Clin Pract; 2019 Apr; 150():301-307. PubMed ID: 30768940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ramadan fasting in diabetes patients on insulin pump therapy augmented by continuous glucose monitoring: an observational real-life study.
    Khalil AB; Beshyah SA; Abu Awad SM; Benbarka MM; Haddad M; Al-Hassan D; Kahwatih M; Nagelkerke N
    Diabetes Technol Ther; 2012 Sep; 14(9):813-8. PubMed ID: 22827507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fasting ramadan in diabetes control status - application of extensive diabetes education, serum creatinine with HbA1c statistical ANOVA and regression models to prevent hypoglycemia.
    Aziz KM
    Recent Pat Endocr Metab Immune Drug Discov; 2013 Sep; 7(3):233-51. PubMed ID: 23964680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care.
    Alawadi F; Rashid F; Bashier A; Abdelgadir E; Al Saeed M; Abuelkheir S; Khalifa A; Al Sayyah F; Bachet F; Elsayed M; Abdallah K; Hassanein M
    Diabetes Res Clin Pract; 2019 May; 151():305-312. PubMed ID: 30880094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycaemic trend during Ramadan in fasting diabetic subjects: a study from Pakistan.
    Ahmadani MY; Riaz M; Fawwad A; Hydrie MZ; Hakeem R; Basit A
    Pak J Biol Sci; 2008 Aug; 11(16):2044-7. PubMed ID: 19266915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Dosage Reduction of Hypoglycemic Multidrug Regimens on the Incidences of Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramaḍān: A Randomized Controlled Trial.
    Zaghlol LY; Beirat AF; Amarin JZ; Hassoun Al Najar AM; Hasan YY; Qtaishat A; Tierney ME; Zaghlol RY; Zayed AA
    Front Endocrinol (Lausanne); 2021; 12():613826. PubMed ID: 34305809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flash glucose monitoring system may benefit children and adolescents with type 1 diabetes during fasting at Ramadan.
    Al-Agha AE; Kafi SE; Zain Aldeen AM; Khadwardi RH
    Saudi Med J; 2017 Apr; 38(4):366-371. PubMed ID: 28397942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of optimum diabetes care in form of Ramadan focused diabetes education, flash glucose monitoring system and pre-Ramadan dose adjustments in the safety of Ramadan fasting in high risk patients with diabetes.
    Hassanein M; Abdelgadir E; Bashier A; Rashid F; Saeed MA; Khalifa A; Eltayb F; Abuelkheir S; Abdellatif M; Sayyah F; Khalifa S; Alawadi F
    Diabetes Res Clin Pract; 2019 Apr; 150():288-295. PubMed ID: 30641167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
    Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG
    Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes.
    Afandi B; Kaplan W; Al Hassani N; Hadi S; Mohamed A
    J Endocrinol Invest; 2017 Jul; 40(7):741-744. PubMed ID: 28239763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Reducing Basal Insulin During Ramadan Fasting by Children and Adolescents with Type 1 Diabetes Decrease the Risk of Symptomatic Hypoglycemia?
    Deeb A; Al Qahtani N; Attia S; Al Suwaidi H; Nagelkerke N
    Diabetes Technol Ther; 2016 Sep; 18(9):539-42. PubMed ID: 27500913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Ramadan-specific education level in patients with diabetes seen at a Primary and a Tertiary care center of Karachi-Pakistan.
    Masood SN; Alvi SF; Ahmedani MY; Kiran S; Zeeshan NF; Basit A; Shera AS
    Diabetes Metab Syndr; 2014; 8(4):225-9. PubMed ID: 25450821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.